Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Gallo

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Journal of the American College of Cardiology|January 23, 2016
Effects of P-Selectin Antagonist Inclacumab in Patients Undergoing Coronary Artery Bypass Graft Surgery: SELECT-CABG TrialBarbara E Stähli, Jean-Claude Tardif, Michel Carrier, et al.
American Heart Journal|October 8, 2013
Prognostic significance of presenting blood pressure in non-ST-segment elevation acute coronary syndrome in relation to prior history of hypertensionDana Lee, Shaun G Goodman, Keith A A Fox, et al.
American Heart Journal|April 1, 2009
Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromesRajeev V Rao, Shaun G Goodman, Raymond T Yan, et al.
The Canadian Journal of Cardiology|August 31, 2011
Use of clopidogrel post-coronary artery bypass surgery in canadian patients with acute coronary syndromesAhmed Krimly, Raymond T Yan, Andrew T Yan, et al.
The Canadian Journal of Cardiology|September 17, 2013
Canadian Cardiovascular Society position statement on radiation exposure from cardiac imaging and interventional proceduresMadhu K Natarajan, Narinder Paul, Mathew Mercuri, et al.
The American Journal of Cardiology|November 15, 2011
Relation between previous angiotensin-converting enzyme inhibitor use and in-hospital outcomes in acute coronary syndromesSheldon M Singh, Shaun G Goodman, Raymond T Yan, et al.
The New England Journal of Medicine|September 8, 2006
Enoxaparin versus unfractionated heparin in elective percutaneous coronary interventionGilles Montalescot, Harvey D White, Richard Gallo, et al.
JACC. Cardiovascular Interventions|November 21, 2009
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trialGilles Montalescot, Richard Gallo, Harvey D White, et al.
American Heart Journal|August 13, 2011
Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromesBasem Elbarouni, Nabeel Ismaeil, Raymond T Yan, et al.
Gastroenterology|July 19, 2011
Cathelicidin signaling via the Toll-like receptor protects against colitis in miceHon Wai Koon, David Q Shih, Jeremy Chen, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Journal of the American College of Cardiology|January 23, 2016
Effects of P-Selectin Antagonist Inclacumab in Patients Undergoing Coronary Artery Bypass Graft Surgery: SELECT-CABG TrialBarbara E Stähli, Jean-Claude Tardif, Michel Carrier, et al.
American Heart Journal|October 8, 2013
Prognostic significance of presenting blood pressure in non-ST-segment elevation acute coronary syndrome in relation to prior history of hypertensionDana Lee, Shaun G Goodman, Keith A A Fox, et al.
American Heart Journal|April 1, 2009
Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromesRajeev V Rao, Shaun G Goodman, Raymond T Yan, et al.
The Canadian Journal of Cardiology|August 31, 2011
Use of clopidogrel post-coronary artery bypass surgery in canadian patients with acute coronary syndromesAhmed Krimly, Raymond T Yan, Andrew T Yan, et al.
The Canadian Journal of Cardiology|September 17, 2013
Canadian Cardiovascular Society position statement on radiation exposure from cardiac imaging and interventional proceduresMadhu K Natarajan, Narinder Paul, Mathew Mercuri, et al.
The American Journal of Cardiology|November 15, 2011
Relation between previous angiotensin-converting enzyme inhibitor use and in-hospital outcomes in acute coronary syndromesSheldon M Singh, Shaun G Goodman, Raymond T Yan, et al.
The New England Journal of Medicine|September 8, 2006
Enoxaparin versus unfractionated heparin in elective percutaneous coronary interventionGilles Montalescot, Harvey D White, Richard Gallo, et al.
JACC. Cardiovascular Interventions|November 21, 2009
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trialGilles Montalescot, Richard Gallo, Harvey D White, et al.
American Heart Journal|August 13, 2011
Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromesBasem Elbarouni, Nabeel Ismaeil, Raymond T Yan, et al.
Gastroenterology|July 19, 2011
Cathelicidin signaling via the Toll-like receptor protects against colitis in miceHon Wai Koon, David Q Shih, Jeremy Chen, et al.
Pageof 7